User: Can you tell me the half life time in humans after IV administration for the molecule with the SMILES CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O?
Assistant: Based on my analysis, the half life time in humans after IV administration for this molecule is approximately 69.000 hours.
User: Can you {#tell me|derive|estimate!} the {half_life_duration__names__noun} for the molecule with the {SMILES__description} {SMILES#}?
Assistant: Based on my analysis, the {half_life_duration__names__noun} for this molecule is approximately {half_life_duration#} {half_life_duration__units}.
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one